Fleisher. D D; Niemiec. S M SM; Oh. C K CK; Hu. Z Z; Ramachandran. C C; Weiner. N N
This lab study showed that putting GHRPâ6 inside tiny fatâbased bubbles (liposomes) helps the peptide move through mouse skin in a dish. The researchers think the same trick could let you apply peptide creams that actually reach deeper skin layers, but they only tested it in vitro, not on people.
Hu. Z Z; Tse. E G EG; Monkhouse. D C DC; Oh. C K CK; Fleisher. D D
In rats, adding glucose to the gut helps the body absorb very small peptide drugs, but it doesnât boost the uptake of larger ones like GHRPâ6. Even though glucose pulls water into the intestine, the size of GHRPâ6 still blocks it from getting through.
In young rat pituitary cells, tiny pieces of the hormone precursor POMC (including the part that looks like GHRPâ6) cause the cells to let calcium flow in, which is a key step for hormone release. About a third of the cells that reacted to these fragments also reacted to GHRPâ6 itself, suggesting they are the growthâhormoneâmaking cells. The calcium entry needs outside calcium and is partly blocked by drugs that target Lâtype calcium channels and the PKA signaling pathway.
Schoen. W R WR; Pisano. J M JM; Prendergast. K K; Wyvratt. M J MJ; Fisher. M H MH; Cheng. K K; Chan....
Scientists made a new small molecule called L-692,429 that mimics the GHâreleasing peptide GHRPâ6 and can trigger the body to release growth hormone. The study shows that a sevenâmembered benzazepinone ring works better than similar sixâ or eightâmembered structures, and computer models suggest it fits the same receptor pocket as the peptide.
In rats, a single shot of GHRPâ6 spikes growth hormone (GH) in all females but only half of the males. When given twice a day for two weeks, males become almost completely tolerant (GH drops to near zero) while females keep getting higher GH levels. The male tolerance seems linked to somatostatin release and isnât seen when the animals are anesthetized.
Hanew. K K; Utsumi. A A; Sugawara. A A; Shimizu. Y Y; Abe. K K
In people with acromegaly (a condition where they already have too much growth hormone), a single dose of the peptide GHRPâ6 raised GH levels in most of them. When GHRPâ6 was given together with another peptide, GHRH, the GH spike was even bigger, but mixing it with TRH didnât add anything.
Scientists looked at how the growthâhormoneâreleasing peptide GHRPâ6 sticks to thin layers of fatâlike molecules (phospholipids). They found that the peptide can bind to these layers without breaking them, but the strength of the bond depends on the type of phospholipid. In some lipids the bond falls apart when the layer is squeezed, while in others it stays together but changes its glow (fluorescence) in a reversible way.
Gertz. B J BJ; Barrett. J S JS; Eisenhandler. R R; Krupa. D A DA; Wittreich. J M JM; Seibold. J R JR...
Researchers tested a new labâmade compound called Lâ692,429 that mimics the GHâreleasing peptideâ6 (GHRPâ6). In healthy young men, IV doses from 0.05 to 1âŻmg per kilogram caused a clear, doseâdependent rise in growth hormone, with the biggest jump (about 80âŻÂ”g/L) at the highest dose. The drug was generally wellâtolerated, showed a halfâlife of roughly 4âŻhours, and caused only mild, shortâlived increases in cortisol and prolactin, plus occasional flushing.
Ciccarelli. E E; Grottoli. S S; Razzore. P P; Gianotti. L L; Arvat. E E; Deghenghi. R R; Camanni. G...
Hexarelin, a synthetic version of GHRPâ6, boosts growth hormone in healthy people but also raises prolactin levels. In patients with acromegaly the prolactin rise is similar, while people who already have high prolactin (hyperprolactinaemia) donât get the prolactin boost and their GH response is weaker.
Kaiya. Hiroyuki H; Nobata. Shigenori S; Takei. Yoshio Y
The study shows that in seawaterâadapted eels, giving ghrelin (a hormone that usually makes mammals want to eat) reduces how much they drink water, and this effect is separate from the bloodâpressureâlowering hormone ANP. The effect works whether ghrelin is given into the bloodstream or directly into the brain, and it isnât blocked by a common ghrelinâreceptor blocker.
In a lab test, the hormone ghrelin made rheumatoidâarthritis joint cells (MH7A) die by turning on cellâdeath proteins called caspases. When the researchers added a ghrelinâblocking peptide called [DâLysâ] GHRPâ6, the cellâkilling effect went away, showing the effect depends on the ghrelin receptor.
Zhang. Lin L; Cheng. Jian J; Shen. Jie J; Wang. Sheng S; Guo. Chuanyong C; Fan. Xiaoming X
The study shows that the hormone ghrelin can protect gut lining cells from dying in ulcerative colitis, but this protective effect is blocked when the ghrelin receptor antagonist [D-lys3]-GHRP-6 is used. In both cell cultures and mouse models, ghrelinâs antiâdeath action involves the unfolded protein response pathway.
In mice, removing the ghrelin receptor (GHSR) or blocking it with a GHRPâ6âderived antagonist reduced liver infection by the parasite Echinococcus granulosus and lowered inflammation. The study shows that less ghrelin signaling leads to fewer parasite foci and a shift toward antiâinflammatory cytokines, but it does not test the peptide in healthy humans or suggest a practical dosing regimen.
The study looked at how a form of the hormone ghrelin that isnât attached to a fatty acid (desacylghrelin) affects human placental cells in a dish. It found that desacylghrelin can temporarily boost the cellsâ ghrelin receptor levels but later reduces them, and it also stops the cells from maturing properly. The researchers used a ghrelinâreceptor blocker called GHRPâ6 to show that these effects are linked to the receptor.
Zhao. Xiaotong X; Pan. Kai K; Li. Rui R; Liu. Meina M; Li. Duo D; Jia. Pingping P; Han. Zhibo Z; Han...
Scientists made a gel that slowly releases the peptide GHRPâ6 and tested it in mice with sudden kidney damage. The gel boosted certain metabolites and turned on a cellâgrowth pathway, helping kidney cells survive and recover better.
In a rat study, giving the hormone ghrelin helped protect the lungs from severe damage caused by oleic acid, likely by lowering stress inside the cells' endoplasmic reticulum. Blocking ghrelin made the injury worse.
Fowkes. Milan M MM; Lalonde. Tyler T; Yu. Lihai L; Dhanvantari. Savita S; Kovacs. Michael S MS; Luyt...
Scientists made a special version of a ghrelinâlike peptide that can be tagged with a radioactive label for PET scans, aiming to see where the ghrelin receptor is overâactive in diseases like cancer or heart failure. The best candidate was a peptidomimetic called Gâ7039, which showed good binding and could be labeled efficiently, but the work is focused on imaging, not on using the peptide to boost growth hormone or performance.
Maugham. Michelle L ML; Seim. Inge I; Thomas. Patrick B PB; Crisp. Gabrielle J GJ; Shah. Esha T ET;...
In a mouse study, giving the ghrelinâreceptor blocker [DâLysÂł]âGHRPâ6 for two weeks shrank prostate cancer tumors a bit, but the effect vanished after a few more days as the tumors became resistant. The drug also lowered EGFR levels in the tumors, but overall it didnât provide a lasting benefit.
Subirós. Nelvys N; Pérez-Saad. Héctor M HM; Berlanga. Jorge A JA; Aldana. Lizet L; Ga...
In a rodent study, giving a mix of human epidermal growth factor (EGF) and the peptide GHRPâ6 right after a short, severe stroke helped the animals survive better, move better, and have smaller brain damage. The benefit was seen when the drugs were given within about four hours after the stroke, using specific doses (100âŻÂ”g/kg EGF and 600âŻÂ”g/kg GHRPâ6).
Scientists found that a brain peptide called cortistatin can calm down a type of immune cell (Th17) that drives inflammation. It does this by slowing down the cell's sugarâburning (glycolysis) through a pathway involving the proteins Myc and HK2, and it needs the growthâhormone secretagogue receptor (GHSR1) to work. In a mouse model of gut inflammation, giving cortistatin reduced the harmful Th17 response, but blocking GHSR1 stopped this benefit.